A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : CR / clinical remission

[Related PubMed/MEDLINE]
Total Number of Papers: 92
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   CR  (>> Co-occurring Abbreviation)
Long Form:   clinical remission
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Mast Cell Infiltration Is Associated With Persistent Symptoms and Endoscopic Abnormalities Despite Resolution of Eosinophilia in Pediatric Eosinophilic Esophagitis. EoE, HI, MCs
2019 Clinical value of CT-P13 trough levels, an infliximab biosimilar, in the management of inflammatory bowel disease. CLN, IBD, IFX, PR, PRO
2019 Depression Outcomes in Smokers and Nonsmokers: Comparison of Collaborative Care Management Versus Usual Care. AOR, CCM, PDS, PHQ-9, UC
2019 Effects of vedolizumab in Japanese patients with Crohn's disease: a prospective, multicenter, randomized, placebo-controlled Phase 3 trial with exploratory analyses. CD, CDAI, CI, OR
2019 Efficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn's disease patients who failed infliximab therapy: the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition experience. ADA, CD, PCDAI
2019 Prognostic Factors for Clinical Response in Systemic Lupus Erythematosus Patients Treated by Allogeneic Mesenchymal Stem Cells. LDA, SLE, SLEDAI
2019 Prolonged clinical remission and low disease activity statuses are associated with better quality of life in systemic lupus erythematosus. CI, HRQoL, LDA, SLE, SLEQoL
2019 Tonsillectomy plus steroid pulse therapy is the most effective treatment in adult patients with C-Grade I IgA nephropathy, and the weight of the extracted palatine tonsils and Yamamoto scale have no significant correlation with the effects of this treatment. IgAN, RASi, TSP
2019 Treatment target in newly diagnosed Systemic Lupus Erythematosus. LLDAS, SLE
10  2019 Vedolizumab in Combination With Corticosteroids for Induction Therapy in Crohn's Disease: A Post Hoc Analysis of GEMINI 2 and 3. CDAI, ECR
11  2018 Analysis of predictive factors for treatment resistance and disease relapse in Takayasu's arteritis. CRP, DR, ESR, TA, TR
12  2018 Clinical efficacy and safety of golimumab in biologically experienced and naive patients with active ulcerative colitis: A real-life experience from two Italian IBD centers. UC
13  2018 Does Medical Acceleration Improve Outcomes in Ulcerative Colitis Patients Who Are in Clinical Remission but Have Endoscopic Inflammation? UC
14  2018 Methotrexate for the Treatment of Pediatric Crohn's Disease: A Systematic Review and Meta-analysis. IBD, MTX
15  2018 Multi-omics monitoring of drug response in rheumatoid arthritis in pursuit of molecular remission. RA
16  2018 Rituximab and intravenous immunoglobulin as alternatives to long-term systemic corticosteroids in the treatment of pemphigus: a single center case series of 63 patients. CS, IVIG, PF, PNP, PV, SR
17  2017 Comparison of oral steroids with tonsillectomy plus steroid pulse therapy in patients with IgA nephropathy. eGFR, IgAN, oPSL, TSP
18  2017 Cross-sectional evaluation of transmural healing in patients with Crohn's disease on maintenance treatment with anti-TNF alpha agents. BS, CD, MH, MRE, TH
19  2017 Distinct Thresholds of Infliximab Trough Level Are Associated with Different Therapeutic Outcomes in Patients with Inflammatory Bowel Disease: A Prospective Observational Study. CRP, fCal, IFX, TLI
20  2017 Docetaxel, bevacizumab, and gemcitabine for very high risk sarcomas in adolescents and young adults: A single-center experience. AYA, LMS, OST, PD, PR, SD
21  2017 Exosomal amyloid A and lymphatic vessel endothelial hyaluronic acid receptor-1 proteins are associated with disease activity in rheumatoid arthritis. AA, CRP, LYVE-1, non-CR, RA
22  2017 Markers influencing the presence of partial clinical remission in patients with newly diagnosed type 1 diabetes. BMI-SDS, HDL, T1D
23  2017 Methotrexate for Refractory Crohn's Disease Compared with Thiopurines: A Retrospective Non-head-to-head Controlled Study. MTX, TPs
24  2017 The size of palatine tonsils cannot be used to decide the indication of tonsillectomy for IgA nephropathy. IgAN, PTs, SPT
25  2016 Cost-effectiveness of clinical remission by treat to target strategy in established rheumatoid arthritis: results of the CREATE registry. RA
26  2016 Fecal Microbiota Transplantation as a Novel Therapy for Ulcerative Colitis: A Systematic Review and Meta-Analysis. FMT, RCTs, UC
27  2016 Fecal Microbiota Transplantation for Ulcerative Colitis: A Systematic Review and Meta-Analysis. CI, FMT, UC
28  2016 Impact of tonsillectomy combined with steroid pulse therapy on immunoglobulin A nephropathy depending on histological classification: a multicenter study. HR, IgAN, TSP
29  2016 Significance of tonsillectomy combined with steroid pulse therapy for IgA nephropathy with mild proteinuria. SCr, ST, TSP
30  2016 Systematic review with meta-analysis: mucosal healing is associated with improved long-term outcomes in Crohn's disease. CD, CI, MH, OR
31  2016 [Clinical outcome after discontinuation of infliximab in patients with ulcerative colitis in deep remission]. IFX, MH, UC
32  2015 Biological treatment in systemic juvenile idiopathic arthritis: achievement of inactive disease or clinical remission on a first, second or third biological agent. BAs, ID, sJIA
33  2015 Different Profile of Efficacy of Thiopurines in Ulcerative Colitis and Crohn's Disease. CD, MH, UC
34  2015 Frequency and prognostic value of cutaneous molecular residual disease in mycosis fungoides: a prospective multicentre trial of the Cutaneous Lymphoma French Study Group. MF, MRD, TCR
35  2015 Impact of the new risk stratification in the 2011 Japanese Society of Nephrology clinical guidelines for IgA nephropathy on incidence of early clinical remission with tonsillectomy plus steroid pulse therapy. IgAN, JSN, TSP
36  2015 Primary bladder lymphoma, diffuse large B-cell type: Case report and literature review of 26 cases. CHOP, DLBCL, MALT, R-CHOP
37  2015 Randomised clinical trial: deep remission in biologic and immunomodulator naive patients with Crohn's disease - a SONIC post hoc analysis. CD, CDAI, CRPnorm, MH
38  2015 Tacrolimus or infliximab for severe ulcerative colitis: short-term and long-term data from a retrospective observational study. IFX, TAC, UC
39  2014 Adalimumab Treatment in Biologically Naive Crohn's Disease: Relationship with Ectopic MUC5AC Expression and Endoscopic Improvement. ADA, CD
40  2014 Comparison between consecutive and intermittent steroid pulse therapy combined with tonsillectomy for clinical remission of IgA nephropathy. CI, HR, SP, TSP
41  2014 Development of an algorithm incorporating pharmacokinetics of adalimumab in inflammatory bowel diseases. AAA, ADA, CD, IBD, IFX, TNF
42  2014 Development of rhinitis may be an indicator for the persistence of childhood asthma. FEV1, FVC
43  2014 Estimated glomerular filtration rate and daily amount of urinary protein predict the clinical remission rate of tonsillectomy plus steroid pulse therapy for IgA nephropathy. eGFR, TSP
44  2014 Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis. CD, FMT, IBD, UC
45  2014 Modulation of peripheral T-cell function by interleukin-7 in rheumatoid arthritis. Bax, Bcl-2, IL-7, OR, PHA, RA
46  2014 Prevalence of ultrasound-detected residual synovitis and risk of relapse and structural progression in rheumatoid arthritis patients in clinical remission: a systematic review and meta-analysis. OR, PD
47  2014 Randomised clinical trial: individualised vs. weight-based dosing of azathioprine in Crohn's disease. 6-TGN, AZA, CD, PP, RBC, TPMT
48  2014 Tonsillectomy efficacy in children with PFAPA syndrome is comparable to the standard medical treatment: a long-term observational study. CRM
49  2013 Achievement of clinical remission in patients with juvenile idiopathic arthritis under a 2-10-year Etanercept exposure. ACRpedi, ETN
50  2013 Tonsillectomy with steroid pulse therapy has more effect on the relapse rate than steroid pulse monotherapy in IgA nephropathy patients. IgAN, SP
51  2013 Transmural healing evaluated by bowel sonography in patients with Crohn's disease on maintenance treatment with biologics. CD, MH, TH, TNF
52  2012 A long-term follow-up study of methotrexate in juvenile localized scleroderma (morphea). JLS, MTX
53  2012 Inactive disease and remission in childhood-onset systemic lupus erythematosus. cSLE, ID, MAL
54  2012 Multiple myeloma vs. breast cancer patients with bisphosphonates-related osteonecrosis of the jaws: a comparative analysis of response to treatment and predictors of outcome. BC, BRONJ, CI, MM
55  2012 Retrospective comparison of the efficacy of tonsillectomy with and without steroid-pulse therapy in IgA nephropathy patients. IgAN, TSP
56  2012 Significance of the duration of nephropathy for achieving clinical remission in patients with IgA nephropathy treated by tonsillectomy and steroid pulse therapy. DN, IgAN, TSP
57  2011 Changes in hand bone mineral density and the association with the level of disease activity in patients with rheumatoid arthritis: bone mineral density measurements in a multicenter randomized clinical trial. DAS, HDA, LDA, mBMD, RA, RR
58  2011 Mesalazine granules are superior to Eudragit-L-coated mesalazine tablets for induction of remission in distal ulcerative colitis - a pooled analysis. ER, OD, tds
59  2011 Nodular lymphocyte predominant Hodgkin lymphoma and diffuse large B-cell lymphoma: a study of six cases concurrently involving the same site. DLBCL, FDC, NLPHL, R-CHOP
60  2011 Tonsillectomy combined with steroid pulse therapy induces clinical remission of IgA nephropathy. IgAN, UP
61  2010 Clinical effectiveness of steroid pulse therapy combined with tonsillectomy in patients with immunoglobulin A nephropathy presenting glomerular haematuria and minimal proteinuria. CI, HR, IgAN
62  2009 Tonsillectomy and steroid pulse (TSP) therapy for patients with IgA nephropathy: a nationwide survey of TSP therapy in Japan and an analysis of the predictive factors for resistance to TSP therapy. ROC, TSP
63  2009 Voting With their Feet (VWF) endpoint: a meta-analysis of an alternative endpoint in clinical trials, using 5-ASA induction studies in ulcerative colitis. 5-ASA, CI, RCT, RR, UC, VWF
64  2008 Flow-cytometric monitoring of disease-associated expression of 9-O-acetylated sialoglycoproteins in combination with known CD antigens, as an index for MRD in children with acute lymphoblastic leukaemia: a two-year longitudinal follow-up study. ALL, BM, MRD, PB
65  2007 Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi). aaIPI, CY, DLBCL, EFS, HD, hd-Mito, OS, PBPC
66  2006 Bone marrow histopathological and molecular changes of small B-cell lymphomas after rituximab therapy: comparison with clinical response and patients outcome. CLL, FL, HCL, HP, HR, LPL, MCL, MZL, RTX
67  2006 Comparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months. HLA
68  2006 Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research. ALL, CI, RR, TBI
69  2005 Protein microarray analysis of disease activity in pediatric inflammatory bowel disease demonstrates elevated serum PLGF, IL-7, TGF-beta1, and IL-12p40 levels in Crohn's disease and ulcerative colitis patients in remission versus active disease. AD, CD, IBD, UC
70  2003 Clinical implications of a rising serum CA-125 within the normal range in patients with epithelial ovarian cancer: a preliminary investigation. CV
71  2002 Correlation of blood lymphocyte CTLA-4 (CD152) induction in Hodgkin's disease with proliferative activity, interleukin 2 and interferon-gamma production. HD, IFN, rIL-2
72  2002 Retinoic acid resistance in acute promyelocytic leukemia. APL, ATRA
73  2001 Monotherapy with rituximab induces rapid remission of recurrent cold agglutinin-mediated hemolytic anemia in a patient with indolent lympho-plasmacytic lymphoma. LPD
74  2001 Prospective monitoring of minimal residual disease in acute myeloid leukemia with inversion(16) by CBFbeta/MYH11 RT-PCR: implications for a monitoring schedule and for treatment decisions. AML, BM, MR, PB
75  2001 Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemia. CML, RT-PCR
76  2000 Association between increased levels of TNF-alpha, decreased levels of prealbumin and retinol-binding protein, and disease outcome. APP, ND, PA, RBP, TNF-alpha
77  2000 Combined use of reverse transcriptase polymerase chain reaction and flow cytometry to study minimal residual disease in Philadelphia positive acute lymphoblastic leukemia. allo-SCT, FC, MRD, RT-PCR
78  1999 [The monitoring of BCR-ABL mRNA by reverse transcription PCR in patients undergoing allogeneic bone marrow transplantation for acute lymphoblastic leukemia with a positive Philadelphia chromosome]. BMT, MRD
79  1996 A comparison of serum haptoglobin levels between acute exacerbation and clinical remission in asthma. AE, Hp
80  1996 Outcome of high-dose therapy and autologous transplantation in non-Hodgkin's lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest. ABMT, HDT, NHL, PSCT
81  1995 Purging of peripheral blood stem cells yields BCR-ABL-negative autografts in patients with BCR-ABL-positive acute lymphoblastic leukemia. ALL, GMALL, IMB, mAbs, PB, PBSC, PBSC, rhG-CSF, RT-PCR, TNC
82  1995 [Clinical significance and prognostic detection of minimal residual disease in acute leukemias]. IF, MRD
83  1995 [Detection of minimal residual disease in acute leukemias by immunophenotyping of bone marrow cells]. IF, MRD
84  1994 Rapid achievement of PML-RAR alpha polymerase chain reaction (PCR)-negativity by combined treatment with all-trans-retinoic acid and chemotherapy in acute promyelocytic leukemia: a pilot study. APL, ATRA, CT, MRD, PCR, RT-PCR
85  1994 [Detection on BCR-ABL fusion gene in Ph1 chromosome positive leukemia by "nested" retrotranscriptase/polymerase chain reaction]. CML
86  1993 Acute promyelocytic leukemia: clinical relevance of two major PML-RAR alpha isoforms and detection of minimal residual disease by retrotranscriptase/polymerase chain reaction to predict relapse. APL, ATRA
87  1993 Remission of myasthenia gravis: clinical, electrophysiological and immunological studies. anti-AChR, GI, MG, SFEMG
88  1991 Intensive chemotherapy for adult lymphoblastic lymphomas. ---
89  1990 Autologous bone marrow transplantation (ABMT) in acute myelogenous leukaemia--Heidelberg experience. ABMT
90  1990 Detection of minimal residual disease in acute myeloid leukemia. AML, CSF
91  1989 [Large cell anaplastic lymphoma in children--clinical experiences with a newly defined histologic entity]. LCAL, MH, pts
92  1984 Vincristine, cisplatin, and bleomycin with surgery in the management of advanced metastatic nonseminomatous testis tumors. NSTT, VCR